Nurse Practitioner, Psychiatric/Mental Health · Portsmouth, OH
NPI
1003255266
Since 2013
Specialty
Nurse Practitioner, Psychiatric/Mental Health
Code 363LP0808X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
901 Washington St
Portsmouth, OH, 45662
Phone (740) 354-1010
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$740K
2,165 prescriptions
Company payments, 2025
$84K
From 14 companies
Medicare prescription drug claims, 2024
In 2024, the drug Crystal M Travis prescribed most often to Medicare patients was Vraylar (Cariprazine Hcl), with 146 prescriptions and refills. In total Crystal M Travis wrote 2,165 Medicare prescriptions that cost $740K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-12-12.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Vraylar Cariprazine Hcl | 146 | 146 | 22 | $160K |
| Alprazolam Generic | 128 | 128 | 19 | $641 |
| Clonazepam Generic | 107 | 107 | 18 | $520 |
| Lamotrigine Generic | 106 | 123 | 17 | $745 |
| Lorazepam Generic | 104 | 104 | 17 | $627 |
| Auvelity Dextromethorphan Hbr/Bupropion | 103 | 111 | 18 | $126K |
| Trazodone Hcl Generic | 81 | 94 | 12 | $441 |
| Diazepam Generic | 80 | 80 | 16 | $651 |
| Risperidone Generic | 79 | 101 | 14 | $1,124 |
| Duloxetine Hcl Generic | 79 | 97 | 14 | $815 |
| Amitriptyline Hcl Generic | 72 | 80 | Under 11 | $661 |
| Zolpidem Tartrate Generic | 60 | 60 | Under 11 | $434 |
| Hydroxyzine Hcl Generic | 58 | 64 | 13 | $892 |
| Aripiprazole Generic | 53 | 71 | 13 | $5,267 |
| Sertraline Hcl Generic | 52 | 64 | 11 | $227 |
Brand drugs: 425 claims; generic drugs: 1,740 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Crystal M Travis $84K ($84K in general payments such as food, travel and fees) from 14 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $41K.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 108 | $41K |
| Axsome Therapeutics, Inc. AXSM | 65 | $22K |
| Abbvie Inc. ABBV | 53 | $12K |
| Vanda Pharmaceuticals Inc. VNDA | 30 | $8,336 |
| Teva Pharmaceuticals USA, Inc. TEVA | 12 | $394 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 19 | $326 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 15 | $172 |
| Alkermes, Inc. ALKS | 5 | $77.19 |
| Janssen Pharmaceuticals, Inc JNJ | 2 | $64.15 |
| Neurocrine BioSciences, Inc. NBIX | 2 | $35.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.